Discover BRCA Map, a cutting-edge NGS panel for comprehensive BRCA1 and BRCA2 gene sequencing. Identify hereditary breast and ovarian cancer risks with precision, guided by expert genetic counseling and advanced bioinformatics.
Explore DNA OncoNex, MapmyGenome’s cutting-edge NGS assay for esophageal cancer. Detect driver mutations, guide targeted therapies, and optimize treatment with comprehensive genetic profiling.
Explore how DNA OncoNex offers a comprehensive Next Generation Sequencing (NGS) assay for head & neck cancer, providing advanced genomic insights to guide personalized treatment strategies and improve patient outcomes.
Discover DNA OncoNex, a comprehensive NGS assay for lung cancer that analyzes 100 genes to identify driver mutations, guide targeted therapies, and improve patient outcomes. Learn how our advanced genomic approach provides insights into lung cancer diagnosis and treatment.
Discover MapmyGenome's Pheochromocytoma Panel for identifying genetic mutations linked to adrenal tumors. Get accurate diagnosis, personalized treatment options, and genetic counseling.
Explore DNA OncoNex for thyroid cancer, a cutting-edge NGS assay analyzing 70 genes associated with thyroid cancer. Understand driver mutations, improve diagnosis, and tailor treatments with our comprehensive genomic approach.